-
17:55
-18:02
Risk stratification of cervical precancerous lesions based on combined detection of cytology, HR-HPV DNA and p16/Ki-67 dual staining
-
18:02
-18:09
Circulating miRNA signatures in cancer-free BRCA1/2 pathogenic variant carriers reveal genetically supported links to ovarian cancer susceptibility
-
18:09
-18:16
Atypical squamous cells cannot exclude high-grade squamous intraepithelial lesion cytologic interpretation and histologic outcomes: a five-year study at a tertiary care center
-
18:16
-18:23
Traction-guided incremental excision during LEEP: technique and eight-year outcomes
-
18:23
-18:30
Progress toward cervical cancer elimination in North Sumatra, Indonesia: a province-wide assessment of screening coverage, health system capacity, and HPV DNA implementation
-
18:30
-18:37
Addressing over-referral in cervical cancer screening: DNA methylation triage with PAX1/JAM3
-
18:37
-18:44
Validation of dual gene methylation in cervical scrapings as a triage tool for endometrial cancer in women with abnormal uterine bleeding
-
18:44
-18:51
Patient self-sampling for CDO1/CELF4 methylation testing as a molecular triage strategy for endometrial cancer in Northwest China

